SCHEMBL22871807

SCHEMBL22871807

CC1(C)c2ccccc2N(c2ccc3c(c2)Oc2cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)ccc2O3)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.37
ADORA2A P29274 3/20 0.37
ADORA3 P0DMS8 2/20 0.37
MEN1 O00255 12/20 0.35
KMT2A Q03164 12/20 0.35
MAPT P10636 9/20 0.35
ALDH1A1 P00352 9/20 0.35
HPGD P15428 8/20 0.35
NTSR1 P30989 1/20 0.35
KDM4E B2RXH2 8/20 0.34
LMNA P02545 3/20 0.34
CYP2C19 P33261 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
POLB P06746 2/20 0.32
GLA P06280 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22871809 0.97 ADORA1 (0.40) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230744 0.93 MEN1 (0.35) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230605 0.93 POLB (0.35) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230616 0.91 ADORA1 (0.34) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230745 0.90 MEN1 (0.37) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230609 0.88 USP2 (0.34) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230617 0.87 USP2 (0.33) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL22871831 0.86 MEN1 (0.32) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230740 0.86 ADORA2A (0.34) ADORA1ADORA2AADORA3MEN1KMT2A
SCHEMBL20230569 0.86 POLB (0.33) ADORA1ADORA2AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 ADORA1 3711/4885ADORA2A 4680/4885ADORA3 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.